Ajay Devgn Moves Bombay High Court Against Maharashtra FDA Notice Over Vimal Advertisement

Legal Challenge in the Vimal Elaichi Advertisement Case

Actor Ajay Devgn has reportedly approached the Bombay High Court in connection with a notice issued by the Maharashtra Food and Drug Administration (FDA). The legal development stems from an ongoing inquiry into surrogate advertisements involving prominent film personalities.

According to state FDA authorities, notices were previously issued to several actors, including Shah Rukh Khan, Tiger Shroff, and Ajay Devgn. Official statements indicate that the procedural hearings regarding the matter have concluded, paving the way for subsequent administrative or legal actions.

FDA Official Briefs on Proceedings

Maharashtra FDA Chief Tukaram Mundhe addressed the media, sharing updates regarding the status of the case. While procedural hearings have wrapped up, the involvement of the judiciary through Ajay Devgn's petition adds a new dimension to the proceedings.

Key aspects of the development include:

• Notices Issued: Prominent actors, including Ajay Devgn, Shah Rukh Khan, and Tiger Shroff, received notices concerning surrogate advertisements.
• Hearing Completion: State FDA officials confirmed that the hearing process has been completed.
• Judicial Intervention: Ajay Devgn has filed a challenge against the notice in the Bombay High Court.

Practical Implications and Verification

For citizens and stakeholders following government and regulatory actions regarding surrogate advertising, legal challenges highlight the complex interplay between statutory bodies and celebrity endorsements. Official announcements and case statuses can typically be verified through official Maharashtra FDA communications or court cause lists available on the Bombay High Court's official portal. Observers should rely on direct court filings or verified press releases from regulatory bodies for accurate updates.